In conclusion, TGFBI downregulation appears to be a consequence of EBV infection and, more specifically, of LMP1 expression, which activates the NF-κB pathway and locally recruits the DNA methyltransferase DNMT1 to the CpG sites of interest. The gene discussed is NFKB1; the disease is Epstein-Barr virus infection.